Paroxetine with pindolol augmentation: a double-blind, randomized, placebo-controlled study in depressed in-patients.

Christian Geretsegger; Waltraud Bitterlich; Renate Stelzig; Christoph Stuppaeck; Brigitta Bondy; Wolfgang Aichhorn

doi:10.1016/j.euroneuro.2007.09.002

Paroxetine with pindolol augmentation: a double-blind, randomized, placebo-controlled study in depressed in-patients.

Christian Geretsegger^* (First author)
, Waltraud Bitterlich
, Renate Stelzig
, Christoph Stuppaeck
, Brigitta Bondy
, Wolfgang Aichhorn (Last author)

^*Corresponding author for this work

Department of Psychiatry and Psychotherapy

Research output: Contribution to journal › Original Article › peer-review

23 Citations (Web of Science)

Original language	English
Pages (from-to)	141-146
Journal	EUROPEAN NEUROPSYCHOPHARMACOLOGY
Volume	18
Issue number	2
DOIs	https://doi.org/10.1016/j.euroneuro.2007.09.002
Publication status	Published - 2008

Keywords

SEROTONIN REUPTAKE INHIBITORS
CONTROLLED-TRIAL
ANTIDEPRESSANT TREATMENT
BIPOLAR DEPRESSION
PATIENTS RESISTANT
MAJOR DEPRESSION
TIME-COURSE
FLUOXETINE
ACCELERATION
COMBINATION

Access to Document

10.1016/j.euroneuro.2007.09.002

Cite this

Geretsegger, C., Bitterlich, W., Stelzig, R., Stuppaeck, C., Bondy, B., & Aichhorn, W. (2008). Paroxetine with pindolol augmentation: a double-blind, randomized, placebo-controlled study in depressed in-patients. EUROPEAN NEUROPSYCHOPHARMACOLOGY , 18(2), 141-146. https://doi.org/10.1016/j.euroneuro.2007.09.002

Geretsegger, Christian ; Bitterlich, Waltraud ; Stelzig, Renate et al. / Paroxetine with pindolol augmentation: a double-blind, randomized, placebo-controlled study in depressed in-patients. In: EUROPEAN NEUROPSYCHOPHARMACOLOGY 2008 ; Vol. 18, No. 2. pp. 141-146.

@article{cf1dc637fdc24a3bae5aa360d2e594b9,

title = "Paroxetine with pindolol augmentation: a double-blind, randomized, placebo-controlled study in depressed in-patients.",

keywords = "SEROTONIN REUPTAKE INHIBITORS, CONTROLLED-TRIAL, ANTIDEPRESSANT TREATMENT, BIPOLAR DEPRESSION, PATIENTS RESISTANT, MAJOR DEPRESSION, TIME-COURSE, FLUOXETINE, ACCELERATION, COMBINATION",

author = "Christian Geretsegger and Waltraud Bitterlich and Renate Stelzig and Christoph Stuppaeck and Brigitta Bondy and Wolfgang Aichhorn",

year = "2008",

doi = "10.1016/j.euroneuro.2007.09.002",

language = "English",

volume = "18",

pages = "141--146",

journal = "EUROPEAN NEUROPSYCHOPHARMACOLOGY ",

issn = "0924-977X",

number = "2",

}

Geretsegger, C, Bitterlich, W, Stelzig, R, Stuppaeck, C, Bondy, B & Aichhorn, W 2008, 'Paroxetine with pindolol augmentation: a double-blind, randomized, placebo-controlled study in depressed in-patients.', EUROPEAN NEUROPSYCHOPHARMACOLOGY , vol. 18, no. 2, pp. 141-146. https://doi.org/10.1016/j.euroneuro.2007.09.002

Paroxetine with pindolol augmentation: a double-blind, randomized, placebo-controlled study in depressed in-patients. / Geretsegger, Christian (First author); Bitterlich, Waltraud; Stelzig, Renate et al.
In: EUROPEAN NEUROPSYCHOPHARMACOLOGY , Vol. 18, No. 2, 2008, p. 141-146.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Paroxetine with pindolol augmentation: a double-blind, randomized, placebo-controlled study in depressed in-patients.

AU - Geretsegger, Christian

AU - Bitterlich, Waltraud

AU - Stelzig, Renate

AU - Stuppaeck, Christoph

AU - Bondy, Brigitta

AU - Aichhorn, Wolfgang

PY - 2008

Y1 - 2008

KW - SEROTONIN REUPTAKE INHIBITORS

KW - CONTROLLED-TRIAL

KW - ANTIDEPRESSANT TREATMENT

KW - BIPOLAR DEPRESSION

KW - PATIENTS RESISTANT

KW - MAJOR DEPRESSION

KW - TIME-COURSE

KW - FLUOXETINE

KW - ACCELERATION

KW - COMBINATION

U2 - 10.1016/j.euroneuro.2007.09.002

DO - 10.1016/j.euroneuro.2007.09.002

M3 - Original Article

C2 - 18054209

SN - 0924-977X

VL - 18

SP - 141

EP - 146

JO - EUROPEAN NEUROPSYCHOPHARMACOLOGY

JF - EUROPEAN NEUROPSYCHOPHARMACOLOGY

IS - 2

ER -

Geretsegger C, Bitterlich W, Stelzig R, Stuppaeck C, Bondy B, Aichhorn W. Paroxetine with pindolol augmentation: a double-blind, randomized, placebo-controlled study in depressed in-patients. EUROPEAN NEUROPSYCHOPHARMACOLOGY . 2008;18(2):141-146. doi: 10.1016/j.euroneuro.2007.09.002